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A 52-year-old man undergoing continuous ambulatory peritoneal dialysis presented
with two consecutive episodes of peritonitis caused by unusual organisms, namely,
Brevibacterium and Pantoea agglomerans. The patient was successfully treated with a
2-week course of cefazolin and ceftazidime for the Brevibacterium-associated perito-
nitis, and a 3-week course of gentamicin for the P. agglomerans-associated peritonitis.
Although these environmental organisms are rarely responsible for human infection,
the number of reported cases of human infection by these unusual organisms has
increased. This report emphasizes the potential for infection by environmental
organisms in patients undergoing peritoneal dialysis.
& 2012. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Peritonitis and exit site infection are common and serious
complications in patients undergoing peritoneal dialysis that
can cause signiﬁcant morbidity. The organisms that are com-
monly isolated in such patients are Gram-positive and aerobic
Gram-negative bacteria. However, culture of the peritoneal ﬂuid
sometimes reveals unusual microorganisms. We report the case
of a patient who experienced two consecutive episodes of
peritonitis while undergoing peritoneal dialysis, caused by
Brevibacterium and Pantoea agglomerans. To date, a limited
number of clinical cases associated with these organisms have
been described.rean Society of Nephrology. P
ses/by-nc-nd/4.0/).
nal Medicine, Chonnam
g-ro, Gwangju, 501-757,
im).Case report
A 52-year-old man undergoing continuous ambulatory peri-
toneal dialysis (CAPD) with no prior peritonitis presented with
abdominal discomfort and cloudy peritoneal ﬂuid that had
persisted for 7 day. He had a history of hypertension and liver
cirrhosis, and had been maintained on CAPD since June 2009.
Physical examination revealed mild generalized abdominal
tenderness. The presence of turbid peritoneal ﬂuid with a white
blood cell (WBC) count of 11000 cells/mm3 (86% neutrophils)
indicated CAPD peritonitis. A 50-mL sample of peritoneal ﬂuid
was centrifuged at 3000g for 15 minutes, followed by resuspen-
sion of the sediment in 3–5 mL of sterile saline and inoculation
on solid culture medium. Immediately after sampling, the
patient was treated empirically with intraperitoneal cefazolin
(1 g/day) and ceftazidime (1 g/day) on an outpatient basis, as
per his request. After 72 hours of aerobic incubation on blood
agar, pigmented colonies with a white-gray appearance were
detected. The organism was identiﬁed as Brevibacterium, which
was resistant to clindamycin, erythromycin, penicillin andublished by Elsevier. This is an open access article under the CC BY-NC-
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gentamicin, tetracycline, and trimethoprim–sulfamethoxazole.
After the patient returned home, the peritonitis quickly
responded to treatment within 2 day; the patient’s clinical
state improved and the dialysate became clear. He continued
antibiotic treatment for 2 weeks and recovered completely
from peritonitis, which was conﬁrmed in the outpatient clinic
by dialysate analysis. Five weeks later, the patient visited the
emergency department, presenting with colicky abdominal
pain and vomiting that had persisted for 3 day. He had also
suffered from diarrhea over the previous 5 day. Physical
examination revealed a distended and tender abdomen with
increased bowel sounds. The catheter exit site was clean,
without evidence of erythema or discharge. Laboratory data
showed peripheral leukopenia, with a WBC count of 3200
cells/mm3 (87.3% neutrophils). Serum C-reactive protein
(CRP) was 5.3 mg/dL. The dialysate ﬂuid was cloudy and
analysis of peritoneal ﬂuid demonstrated a high WBC count
(5940 cells/mm3), consisting mainly of neutrophils (91%).
Samples of dialysate efﬂuent were obtained using an
aseptic technique and processed using the same method as
that for the ﬁrst peritonitis episode. The patient was imme-
diately started on intraperitoneal antibiotic treatment with
cefazolin (1 g/day) and gentamicin (40 mg/day) on admission.
His serum CRP level increased to 9.3 mg/dL after admission.
By 48 hours after inoculation of peritoneal samples on
blood agar, Gram-negative bacteria belonging to the Enter-
obacteriaceae family were isolated. Further analysis identiﬁed
the bacteria as P. agglomerans. The bacteria were sensitive
to all antibiotics tested, including ampicillin, ceftazidime,
cefoxitin, ciproﬂoxacin, gentamicin, tetracycline, imipenem,
and piperacillin. On the basis of these results, cefazolin
was discontinued after 3 day, whereas gentamicin treatment
was continued. The patient’s abdominal pain improved and
the peritoneal ﬂuid became clear by the third day of
treatment. His CRP level dropped to 1.35 mg/dL on hospital
Day 7, and analysis of peritoneal ﬂuid revealed steady
improvements in peritonitis, as evidenced by a reduction in
peritoneal ﬂuid WBC count (190 and 30 cells/mm3 on hospital
Days 7 and 14, respectively). Antibiotic treatment with
gentamicin was continued for 3 weeks and the patient was
discharged.Discussion
The patient experienced two consecutive episodes of
peritonitis in a relatively short period of time, both of which
were caused by environmental organisms. These organisms
have rarely been reported as being responsible for clinically
signiﬁcant infections in humans.
Brevibacterium spp. are Gram-positive, irregular, rod-shaped,
non-acid-fast bacteria that resemble corynebacteria. The main
habitat of Brevibacterium is dairy products, in which the bacteria
contribute to the aroma and color of the product; they are also
found on human skin surfaces and genital hair, and have been
associated with otorrhea [1–3]. A few cases of Brevibacterium-
induced disease have been reported, but little is known about
the optimal choice of antibiotics or treatment duration for such
infections [4,5]. Although we did not identify the speciﬁc
Brevibacterium strain in the present patient, our results suggest
that Brevibacterium-associated peritonitis may be susceptible to
cephalosporin antibiotics.Pantoea agglomerans (formerly Enterobacter agglomerans) is
a Gram-negative aerobic bacillus belonging to the Enterobac-
teriaceae family. It is ubiquitous and is found in human and
animal feces, and especially in plants, fruits, and vegetables.
Recently, cases of P. agglomerans-associated peritonitis in
peritoneal dialysis patients have been increasingly reported
[6–8]. Plant-associated thorn injury was the most common
etiology. However, reported cases of P. agglomerans-associated
peritonitis in patients without plant injury suggest that
gastrointestinal transformation is a possible source of infec-
tion [9,10]. In the present case, our patient was not involved
in gardening and reported that he had not received of any
plant-associated injuries such as from a rose thorn. We found
no signs of any signiﬁcant skin trauma at the time of
P. agglomerans-associated peritonitis. Instead, it is likely that
the patient was prone to infection because of his immuno-
compromised state. In fact, he suffered from liver cirrhosis
and had recently received antibiotic therapy due to the prior
Brevibacterium-associated peritonitis episode. Considering the
preceding occurrence of diarrhea, translocation of bacteria
from the gastrointestinal tract may have been responsible for
this second episode of peritonitis.
The degree of severity was comparable between the two
consecutive peritonitis episodes in the present patient. Brevi-
bacterium-associated peritonitis showed more favorable clin-
ical symptoms, whereas P. agglomerans-associated peritonitis
was associated with more severe symptoms and higher CRP
levels. Our ﬁndings are in line with previous ﬁndings suggest-
ing that Pantoea-associated peritonitis is relatively more
symptomatic, accompanied by fever, nausea, vomiting, and
severe abdominal pain [9,11]. However, it has been reported
that peritonitis associated with P. agglomerans shows good
response to antibiotics such as ciproﬂoxacin and aminoglyco-
side [8–10]. The second episode of peritonitis responded well
to gentamicin treatment in the present patient.
In summary, we report two consecutive episodes of unu-
sual peritonitis caused by different environmental organisms
in a patient undergoing peritoneal dialysis. The patient was
successfully treated with a 2-week course of cefazolin and
ceftazidime for the Brevibacterium-associated peritonitis, and
a 3-week course of gentamicin for the P. agglomerans-asso-
ciated peritonitis. Although these organisms are rarely respon-
sible for human infections, it is important to view them as
pathogens rather than contaminants when isolated in patients
undergoing peritoneal dialysis. Plant-associated thorn injuries
should be assessed in patients with P. agglomerans-associated
peritonitis; less frequently, translocation of bacteria from the
gastrointestinal tract should be considered as the source of
infection.Conﬂict of interest
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